Image 1
Qvar Redihaler Aerosol, Metered
Product Images NDC 59310-302
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Qvar Redihaler (NDC 59310-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Respiratory, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure F (Image 10)
Figure D (Image 11)
This seems to be a combination of text representing a product name and its description. It appears to describe a breath-actuated inhaler used to administer beclomethasone dipropionate, which comes in the form of a metered-dose aerosol. The product comes with a quick guide for lift and a side application. Users must close the white cover before each inhalation. However, the text is difficult to read, likely due to errors.*
Qvar® Redihaler™ (beclomethasone Dipropionate Hfa) 40 Mcg, 120 Metered Inhalations Carton, Part 1 Of 2 (Image 12)
This is a Quick Guide for using a breath-activated inhaler called RediHaler. The medication contained in it is beclomethasone dipropionate HFA, which is delivered in 80 metered doses. The instructions advise to read the complete Instructions for Use before using the inhaler and to not shake or prime the inhaler. The guide also provides steps to prepare and use the inhaler, which include taking a deep breath and holding it while releasing the medication. The item has a net contents of 10.*
Qvar® Redihaler™ (beclomethasone Dipropionate Hfa) 40 Mcg, 120 Metered Inhalations Carton, Part 2 Of 2 (Image 13)
The text seems to be a description of a medication inhaler. The medication name is RediHaler and it contains beclomethasone dipropionate HFA. The inhaler is breath-actuated and has a net content of 104. The text also mentions the need to close the white cap before each inhalation. The contents of the inhaler are not described in detail.*
Image 2
The text appears to be a chart showing changes in baseline measurements over time for different doses of QVAR REDIHALER. The chart shows the time of visit (in weeks) on the x-axis and the change from baseline (in some unit unspecified) on the y-axis. The chart compares the changes between placebo and two different doses (80mcg/day and 160mcg/day) of QVAR REDIHALER.*
Image 3
This data appears to be a graph showing the change in 'Vi' over time for different dosages of QVAR REDIHALER and QVAR MDI as compared to placebo. However, without more context, it is difficult to determine what Vi represents or what the purpose of the graph is.*
Image 4
Image 5
This is a description of an inhaler that contains 120 doses with a dose counter. The counter marks the number of doses used and currently has zero doses left, indicating that the inhaler is empty.*
Image 6
Image 7
Image 8
Image 9
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
